Neurocognitive Outcomes in Type 1 Diabetes, Screening/Early Detection of Type 1 Diabetes and Associated Complications.
Publications
Pauley ME, Coughlan C, Dong F, Bucca B, Tanner B, Chartier-Logan C, Shapiro ALB, Snell-Bergeon JK. Type 1 diabetes is associated with higher plasma levels of biomarkers of neurodegeneration and neuroinflammation. Front Immunol. 2026;17:1860993. PubMed PMID: 42558640
Shapiro ALB, Pauley ME, Moore JM, Hall L, Stence N, Johnson SL, Nadeau KJ, Keller KL, Rolls BJ, Cornier MA, Tregellas JR. Altered hypothalamic functional connectivity in adolescents with severe obesity. Int J Obes (Lond). 2026 Aug;50(8):1818-1827. PubMed PMID: 42230985
Stein A, Pauley M, Snell-Bergeon J. Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes: What We Know So Far and Future Trials. Endocrinol Metab Clin North Am. 2026 Sep;55(3):437-453. PubMed PMID: 42526995
Pauley ME, Simmons KM, Dong F, Yu L, Steck AK, Rasmussen CG, Frohnert BI, Rewers MJ. Prevalence of Islet Autoantibodies in Adults Without Diabetes. J Endocr Soc. 2025 Aug;9(8):bvaf095. PubMed PMID: 40496897
Pauley ME, Coughlan C, Snell-Bergeon JK, Dabelea D, Bellatorre A, Shah A, Dolan LM, Pihoker C, Reynolds K, Shapiro ALB. P-683: Preclinical biomarkers of neural damage in youth with type 1 diabetes (T1D): the SEARCH for diabetes in youth study journal. Horm Res in Paediatr. 2025 Nov 6. 98 (Suppl. 4): 1–456.
Shapiro ALB, Coughlan C, Bettcher BM, Pauley ME, Kim J, Bjornstad P, Rajic B, Truong J, Bell C, Choi YJ, Walker KA, Potter H, Liese AD, Dabelea D, Whitlow CT. Biomarkers of Neurodegeneration and Alzheimer's Disease Neuropathology in Adolescents and Young Adults with Youth-Onset Type 1 or Type 2 Diabetes: A Proof-of-Concept Study. Endocrines. 2024 Jun;5(2):197-213. PubMed PMID: 38764894
Pauley ME, Vinovskis C, MacDonald A, Baca M, Pyle L, Wadwa RP, Fornoni A, Nadeau KJ, Pavkov M, Nelson RG, Gordin D, de Boer IH, Tommerdahl KL, Bjornstad P. Triglyceride content of lipoprotein subclasses and kidney hemodynamic function and injury in adolescents with type 1 diabetes. J Diabetes Complications. 2023 Feb;37(2):108384. PubMed PMID: 36623423
Alonso GT, Triolo TM, Akturk HK, Pauley ME, Sobczak M, Forlenza GP, Sakamoto C, Pyle L, Frohnert BI. Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population. Diabetes Care. 2023 Jun 1;46(6):1218-1222. PubMed PMID: 37023293
Pauley ME, Tan S, Sikand G, Cobry EC. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes. Clin Diabetes. 2022 Spring;40(2):253-256. PubMed PMID: 35669309
Pauley ME, Tommerdahl KL, Snell-Bergeon JK, Forlenza GP. Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits. Curr Cardiol Rep. 2022 Dec;24(12):2043-2056. PubMed PMID: 36279036
Pauley ME, Berget C, Messer LH, Forlenza GP. Barriers to Uptake of Insulin Technologies and Novel Solutions. Med Devices (Auckl). 2021;14:339-354. PubMed PMID: 34803408
Pauley M, Mays C, Bailes JR Jr, Schwartzman ML, Castle M, McCoy M, Patick C, Preston D, Nudelman MJR, Denning KL, Bellner L, Werthammer J. Carbohydrate-Restricted Diet: A Successful Strategy for Short-Term Management in Youth with Severe Obesity-An Observational Study. Metab Syndr Relat Disord. 2021 Jun;19(5):281-287. PubMed PMID: 33566732